Shoulder Innovations (NYSE:SI) Coverage Initiated by Analysts at The Goldman Sachs Group

The Goldman Sachs Group initiated coverage on shares of Shoulder Innovations (NYSE:SI) in a research note published on Monday morning, Marketbeat Ratings reports. The firm issued a buy rating and a $20.00 price objective on the stock.

A number of other research analysts also recently weighed in on SI. Jefferies Financial Group began coverage on Shoulder Innovations in a report on Monday. They set a “buy” rating and a $19.00 target price on the stock. Wall Street Zen raised Shoulder Innovations to a “hold” rating in a research note on Saturday, August 16th. Four investment analysts have rated the stock with a Buy rating, According to MarketBeat, the company has an average rating of “Buy” and an average price target of $20.00.

Shoulder Innovations Stock Performance

Shares of NYSE SI opened at $15.01 on Monday. Shoulder Innovations has a 1 year low of $11.75 and a 1 year high of $17.94. The stock has a market cap of $228.60 million and a P/E ratio of -0.50.

Insider Activity

In related news, Director Casey M. Tansey purchased 40,000 shares of the stock in a transaction dated Friday, August 1st. The stock was purchased at an average price of $15.00 per share, with a total value of $600,000.00. Following the transaction, the director directly owned 47,666 shares in the company, valued at $714,990. This trade represents a 521.78% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, major shareholder Lsv Associates Ii, Llc purchased 266,666 shares of the company’s stock in a transaction that occurred on Friday, August 1st. The stock was purchased at an average price of $15.00 per share, for a total transaction of $3,999,990.00. Following the purchase, the insider owned 1,885,136 shares in the company, valued at $28,277,040. This represents a 16.48% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders purchased 778,382 shares of company stock valued at $11,675,730.

About Shoulder Innovations

We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. These systems are a core element of our ecosystem, which we designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain.